Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and western immunoblotting

Clinical and Diagnostic Laboratory Immunology

Volumn 3, Issue 2, 1996, Pages 184-190

  Creson, Jennifer R ^a,b   Lim, Lony C L ^a,b   Glowacki, Nicole J ^a,b   Callister, Steven M ^c   Schell, Ronald F ^a,b  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CEFTRIAXONE; DOXYCYCLINE;

ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; FLUORESCENT ANTIBODY TECHNIQUE; HAMSTER; IMMUNOBLOTTING; INFECTION; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0029917096     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.3.2.184-190.1996     Document Type: Article

References (18)

1. Aydintug, M. K., Y. Gu, and M. T. Philipp. 1994. Borrelia burgdorferi antigens that are targets by antibody-dependent, complement-mediated killing in the rhesus monkey. Infect. Immun. 62:4929-4937.
2. Bakken, L. L., K. L. Case, S. M. Callister, N. J. Bourdeau, and R. F. Schell. 1992. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 268:891-895.
3. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
4. Callister, S. M., and R. F. Schell. 1994. Importance of protective borreliacidal antibodies in Lyme disease immunity and serodiagnosis. J. Infect. Dis. 170:499.
5. Callister, S. M., and R. F. Schell. 1995. Flow cytometric detection of borreliacidal antibodies: a test for immune status and specific serodiagnosis of Lyme disease. Clin. Immunol. Newsl. 15:41-46.
6. Callister, S. M., K. L. Case, W. A. Agger, R. F. Schell, R. C. Johnson, and J. L. E. Ellingson. 1990. Effects of bovine serum albumin on the ability of Barbour-Stoenner-Kelly medium to detect Borrelia burgdorferi. J. Clin. Microbiol. 28:363-365.
7. Callister, S. M., R. F. Schell, K. L. Case, S. D. Lovrich, and S. P. Day. 1993. Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test. J. Infect. Dis. 167:158-164.
8. Callister, S. M., R. F. Schell, L. C. L. Lim, D. A. Jobe, K. L. Case, G. L. Bryant, and P. E. Molling. 1994. Detection of borreliacidal antibodies by flow cytometry: an accurate, highly specific serodiagnostic test for Lyme disease. Arch. Intern. Med. 154:1625-1632.
9. Chu, H., L. G. Chavez, B. H. Blumer, R. W. Sebring, T. L. Wasmuen, and W. M. Acree. 1992. Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. J. Am. Vet. Med. Assoc. 201:403-418.
10. Coughlin, R. T., D. Fish, T. N. Mather, J. Ma, C. Pavia, and P. Bulger. 1995. Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp)A, OspB and the saponin adjuvant QS21. J. Infect. Dis. 171:1049-1052.
11. Craft, J. E., R. L. Grodzicki, and A. C. Steere. 1984. Antibody response in Lyme disease: evaluation of diagnostic tests. J. Infect. Dis. 149:789-795.
12. Dressler, F., J. A. Whaler, B. N. Reinhardt, and A. C. Steere. 1993. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167:392-400.
13. Dunne, M., B. K. Al-Ramadi, S. W. Barthold, R. A. Flavell, and E. Fikrig. 1995. Oral vaccination with an attenuated Salmonella typhimurium strain expressing Borrelia burgdorferi OspA prevents murine Lyme borreliosis. Infect. Immun. 63:1611-1614.
14. Erdile, L. F., M. A. Brandt, D. J. Warakomski, G. J. Westrack, A. Sadziene, A. G. Barbour, and J. P. Mays. 1993. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:81-90.
15. Feder, H. M., M. A. Gerber, S. W. Luger, and R. W. Ryan. 1992. Persistance of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin. Infect. Dis. 15:788-793.
16. Fikrig, E., S. W. Barthold, N. Marcanonio, K. Deponte, F. S. Kantor, and R. A. Flavell. 1992. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60:657-661.
17. Fikrig, E., L. K. Bockenstedt, S. W. Barthold, M. Chen, H. Tao, P. Ali-Salaam, S. R. Telford, and R. A. Flavell. 1994. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis. J. Infect. Dis. 169:568-574.
18. Fikrig, E., S. R. Telford III, R. Wallich, M. Chen, Y. Lobet, F. R. Matuschka, R. B. Kimsey, F. S. Kantor, S. W. Barthold, A. Spielman, and R. A. Flavell. 1995. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J. Exp. Med. 181:215-221.